## Abstract **Summary:** The scope of drugβdelivery systems has expanded significantly in recent years providing new ways to deliver life saving therapeutics to patients. The development of new injectable drugβdelivery systems has provided new vistas and opened up unexplored horizons in the field o
Biocompatibility of an injectable in situ forming depot for peptide delivery
β Scribed by Karin Schoenhammer; Julie Boisclair; Helmut Schuetz; Holger Petersen; Achim Goepferich
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 291 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The objective of these studies was to develop a leuprolide acetate depot based on an in situ forming drug delivery system (Atrigel(R)) to suppress the pituitary-gonadal axis and in turn the serum testosterone to chemical castration levels for a period of at least 3 months. Formulations with biodegra
## Abstract The fabrication of a novel __in situ__ forming hydrogel composed of a multifunctional poly(ethylene glycol) (PEG) __N__βhydroxysuccinimide ester (NHS) and poly(allylamine hydrochloride) (PAA) was investigated. FTIR confirmed that PAA formed the hydrogel matrix (i.e., the formation of a
In situ ATR-IR spectroscopy has been applied to the study of glutamic (Glu) and aspartic (Asp) acid adsorbed on amorphous TiO 2 particle films. Unlike Asp, which gives evidence of one major adsorbed species, Glu yields several spectroscopically distinct structures upon adsorption to TiO 2 . The pH d